Successful treatment with oral steroid and hydroxychloroquine in a patient with systemic lupus erythematosus upon COVID‐19 infection: A case report with detailed laboratory data. Issue 8 (24th August 2021)

• Record Type: Journal Article
• Authors: Kondo, Makoto; Matsushima, Yoshiaki; Iida, Shohei; Umaoka, Ai; Nakanishi, Takehisa; Habe, Koji; Yamanaka, Keiichi
• Is Part Of: Clinical case reports. Volume 9:Issue 8(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-08-24
• Subjects: COVID‐19 -- hydroxychloroquine -- laboratory data -- steroid -- systemic lupus erythematosus; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.4700
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: The administration of glucocorticoid and hydroxychloroquine (HCQ) may be able to control systemic lupus erythematosus (SLE) activities under COVID‐19 infection by suppress the cytokine storm. Abstract : The administration of glucocorticoid and hydroxychloroquine (HCQ) may be able to control systemic lupus erythematosus (SLE) activities under COVID‐19 infection by suppress the cytokine storm.